Clinical and immuno-virologic outcome in a cohort of immigrant and native subjects with HIV infection in south-eastern Spain during the period 1998–2007 by FJ Vera-Méndez et al.
BioMed Central
Journal of the International AIDS 
Society
ssOpen AccePoster presentation
Clinical and immuno-virologic outcome in a cohort of immigrant 
and native subjects with HIV infection in south-eastern Spain during 
the period 1998–2007
FJ Vera-Méndez*1, J Trujillo-Santos1, A Cano-Sánchez2, JA García-Henarejos1, 
N Cobos-Trigueros1, J García-García1, OJ Martínez-Madrid1, R Vilaplana-
García1, C Pérez-Pagán1, M Alcalde-Encinas1 and V Herrero-Segastume1
Address: 1Hospital Universitario Santa María del Rosell, Cartagena, Spain and 2Hospital General Universitario Reina Sofía, Murcia, Spain
* Corresponding author    
Purpose of the study
To describe the differences of clinical and immuno-viro-
logic outcome in a cohort formed by immigrant and
native patients with HIV infection.
Methods
Retrospective cohort study in which immigrant and native
subjects with HIV infection (ratio 1:3) were included from
January 1, 1998 until September 30, 2007. Both groups
were analyzed after the first clinic visit: CD4 cell count
and viral load at 24 and 48 weeks, respectively, time of
clinical follow-up, AIDS-defining diseases, and the main
causes of mortality.
Summary of results
95 immigrant and 285 native patients with HIV infection
were included. The median baseline CD4 cell count was
268 cells/μl and 244 cells/μl in both groups, respectively
(p = ns).The median baseline viral load was 4.68 log10
and 4.54 log10 copies/ml, respectively (p = ns). There
were no differences in the median of CD4 cell count and
viral load at 24 and 48 weeks of follow-up in the immi-
grant and native population who started HAART therapy
(p = ns).The time of clinical follow-up was higher in the
native population than the immigrant (median = 177 and
82 weeks, respectively, p = 0.001). Forty-three immigrant
(45%) and 102 (36%) native subjects with HIV infection
were lost to follow-up (p = 0.02). The immigrant and
native population developed 14 and 51 AIDS-defining
diseases, respectively, during the follow-up (p = ns).The
most common AIDS-defining diseases were: chronic
diarrhea due to Cryptosporidium (n = 4; 4.2%), tubercu-
losis (n = 3; 3.2%), and recurrent pneumonia (n = 2;
2.1%) in immigrant population; and tuberculosis (n = 12,
4.2%), chronic diarrhea due to Cryptosporidium (n = 11;
3.9%) and wasting syndrome (n = 10; 3.5%) in native
patients. In this cohort, 16 native (5.6%) and three immi-
grant patients (3.2%) died (p = 0.02). The AIDS-defining
diseases were the cause of death in five native patients
(MAC, n = 1; PML, n = 1; NHL, n = 1; PN jiroveci, n = 1;
toxoplasmosis, n = 1) and in one immigrant patient
(CMV, n = 1).
Conclusion
In our cohort, there was no difference in immuno-virolog-
ical outcome in the HIV-positive native and immigrant
population. There was a greater loss of follow-up in immi-
grant patients with HIV infection. We found no differ-
ences in the frequency of AIDS defining illnesses,
tuberculosis and chronic diarrhoea due to Cryptosporid-
ium the diseases being most prevalent in both groups. A
larger number of native patients died from causes unre-
lated to AIDS.
from Ninth International Congress on Drug Therapy in HIV Infection
Glasgow, UK. 9–13 November 2008
Published: 10 November 2008
Journal of the International AIDS Society 2008, 11(Suppl 1):P254 doi:10.1186/1758-2652-11-S1-P254
<supplement> <title> <p>Abstracts of the Ninth International Congress on Drug Therapy in HIV Infection</p> </title> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1758-2652-11-S1-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1758-2652-11-S1-info.pdf</url> </supplement>
This abstract is available from: http://www.jiasociety.org/content/11/S1/P254
© 2008 Vera-Méndez et al; licensee BioMed Central Ltd. Page 1 of 2
(page number not for citation purposes)
Journal of the International AIDS Society 2008, 11(Suppl 1):P254 http://www.jiasociety.org/content/11/S1/P254Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright




1. Staehelin C, et al.: Migrants from Sub-Saharan Africa in the
Swiss HIV Cohort Study: access to antiretroviral therapy,
disease progression and survival.  AIDS 2003, 17:2237-2244.
2. Staehelin C, et al.: Migrants from Subsaharan Africa in the
Swiss HIV Cohort Study: A single center study of epidemio-
logic, migration-specific and clinical features.  Aids Patient Care
2004, 18:665-675.Page 2 of 2
(page number not for citation purposes)
